huahaipharm(SH:600521) Shang Hai Zheng Quan Bao·2025-10-14 20:08Core Viewpoint - The company Zhejiang Huahai Pharmaceutical Co., Ltd. has provided a guarantee for its wholly-owned subsidiary, Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd., to support its business development and funding needs [2][11]. Group 1: Guarantee Details - The total amount of the guarantee provided by the company is capped at 205 million RMB [3][10]. - As of the date of the announcement, the company has already provided a guarantee balance of 495 million RMB to the subsidiary, excluding the current guarantee [5][6]. - The guarantee does not involve any counter-guarantee [8]. Group 2: Implementation Progress - On October 14, 2025, the company signed a guarantee contract with the Industrial and Commercial Bank of China, providing a maximum guarantee of 205 million RMB for the subsidiary [4][10]. Group 3: Subsidiary Information - The subsidiary, Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd., was established on August 4, 2016, and is fully owned by the company [9]. - The main business activities of the subsidiary include drug production, hazardous waste management, and import-export of goods [9]. Group 4: Board Approval and Authorization - The guarantee has been approved by the company's board of directors during a meeting held on August 25, 2025, and the management is authorized to handle related procedures without further board approval [6][13]. - The authorization for management to act on this guarantee is valid for one year from the date of approval [13]. Group 5: Financial Impact - The total amount of external guarantees provided by the company and its subsidiaries is 3.572 billion RMB, which represents 40.15% of the company's latest audited equity attributable to shareholders [13].